HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peginterferon alfa-2b combined with tenofovir disoproxil fumarate induced high clinical cure rate in inactive chronic hepatitis B virus carriers.

AuthorsXue-Bing Chen, Fei-Fei Liu, Fu-Li Shu, Jian-Ying Liu, Jia-Hong Yang
JournalClinics and research in hepatology and gastroenterology (Clin Res Hepatol Gastroenterol) Vol. 45 Issue 5 Pg. 101723 (09 2021) ISSN: 2210-741X [Electronic] France
PMID34091082 (Publication Type: Letter)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Tenofovir
  • peginterferon alfa-2b
Topics
  • Antiviral Agents (therapeutic use)
  • Drug Therapy, Combination
  • Hepatitis B, Chronic (drug therapy, virology)
  • Humans
  • Interferon alpha-2 (therapeutic use)
  • Interferon-alpha (therapeutic use)
  • Polyethylene Glycols (therapeutic use)
  • Recombinant Proteins (therapeutic use)
  • Tenofovir (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: